Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 622.00
+3.60 (0.58%)
At close: Mar 4, 2026
Lincoln Pharmaceuticals Revenue
Lincoln Pharmaceuticals had revenue of 1.66B INR in the quarter ending December 31, 2025, with 13.49% growth. This brings the company's revenue in the last twelve months to 6.52B, up 9.10% year-over-year. In the fiscal year ending March 31, 2025, Lincoln Pharmaceuticals had annual revenue of 6.23B with 7.35% growth.
Revenue (ttm)
6.52B
Revenue Growth
+9.10%
P/S Ratio
1.92
Revenue / Employee
3.52M
Employees
1,853
Market Cap
12.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.23B | 426.81M | 7.35% |
| Mar 31, 2024 | 5.81B | 702.41M | 13.76% |
| Mar 31, 2023 | 5.10B | 381.86M | 8.09% |
| Mar 31, 2022 | 4.72B | 479.38M | 11.30% |
| Mar 31, 2021 | 4.24B | 376.95M | 9.75% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TTK Healthcare | 8.30B |
| Anuh Pharma | 7.68B |
| Venus Remedies | 7.03B |
| Wanbury | 6.58B |
| Fredun Pharmaceuticals | 5.91B |
| Fermenta Biotech | 5.44B |
| Syncom Formulations (India) | 5.03B |
| Amrutanjan Health Care | 4.88B |
Lincoln Pharmaceuticals News
- 8 months ago - Lincoln Pharmaceuticals successfully completes trial run at new API facility in Gujarat - Business Upturn